Showing results (301-310 of 312) with videos related to

Sort By:
Pageof 32
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 25, 2025
Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's diseaseJulie K Wisch, Nicole S McKay, Matthew Zammit, et al.
Research Square|November 24, 2025
The Knight Alzheimer Research Imaging (KARI) dataset: a comprehensive multimodal resource for exploring aging, preclinical, and symptomatic Alzheimer disease pathologyDavid A Hoagey, Nicole S McKay, Nelly Joseph-Mathurin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersJulie K Wisch, Nicole S McKay, Matthew D Zammit, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 19, 2026
Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's diseaseJames T Kennedy, Julie K Wisch, Anna H Boerwinkle, et al.
Neuroimage. Clinical|January 5, 2021
Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer diseaseAylin Dincer, Brian A Gordon, Amrita Hari-Raj, et al.
Multisensory Research|December 10, 2024
Research Priorities for Autonomous Sensory Meridian Response: An Interdisciplinary Delphi StudyThomas J Hostler, Giulia L Poerio, Clau Nader, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2025
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trialAustin McCullough, Charles D Chen, Brian A Gordon, et al.
The Lancet. Neurology|April 17, 2024
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional studyJulie K Wisch, Nicole S McKay, Anna H Boerwinkle, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2023
Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's diseaseCharles D Chen, Austin McCullough, Brian Gordon, et al.
Annals of Neurology|September 24, 2022
Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer DiseaseNelly Joseph-Mathurin, Jorge J Llibre-Guerra, Yan Li, et al.
Pageof 32